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ABSTRACT
Some mutations resulting in protein sequence
change might be tightly related to certain human
diseases by affecting its roles, such as sickle cell
anemia. Until now several databases, such as
PMD, OMIM and HGMD, have been developed, pro-
viding useful information about human disease-
related mutation. Tandem mass spectrometry (MS)
has been used for characterizing proteins in various
conditions; however, there is no system in place
for finding disease-related mutated proteins within
the MS results. Here, a Systematical Platform
for Identifying Mutated Proteins (SysPIMP; http://
pimp.starflr.info/) was developed to efficiently iden-
tify human disease-related mutated proteins within
MS results. SysPIMP comprises of three layers:
(i) a standardized data warehouse, (ii) a pipeline
layer for maintaining human disease databases
and X!Tandem and BLAST and (iii) a web-based
interface. From OMIM AV part, PMD and SwissProt
databases, 35497 non-redundant human disease-
related mutated sequences were collected with
disease information described by OMIM terms.
With the interfaces to browse sequences archived
in SysPIMP, X!Tandem, an open source database-
search engine used to identify proteins within
MS data, was integrated into SysPIMP to help
support the detection of potential human disease-
related mutants in MS results. In addition, together
with non-redundant disease-related mutated
sequences, original non-mutated sequences are
also provided in SysPIMP for comparative research.
Based on this system, SysPIMP will be the platform
for efficiently and intensively studying human dis-
eases caused by mutation.
INTRODUCTION
In biological ﬁelds, mutation has been deﬁned as changes
in the nucleotide sequences, which can cause phenotype
changes, such as the diﬀerent colors of butterﬂies which
can aﬀect the survival rate against predators. When muta-
tions occur in humans, they can inﬂuence individual
survival rates by changing their activities, interaction abil-
ity and/or regulation of speciﬁc proteins at various levels
(1–3). In particular, mutations resulting in amino acid
sequence changes directly increase and/or decrease the
functionality of proteins through conformational changes,
which can cause certain human diseases (2–5). These
mutations can be inherited through the generations, pres-
enting the importance of disease control. For example,
sickle-cell anemia is caused by a point mutation at sixth
codon (G6V) in the hemoglobin beta gene (HBB) that
changes the protein sequence and diminishes the ability
to carry oxygen (6). Phenylketonuria (PKU), which is
found in newborn babies, is triggered by the defective
phenylalanine hydroxylase enzyme (PAH). This disease
is known to be inherited in a recessive manner (7). Due
to their critical eﬀects on humans, protein mutations asso-
ciated with human diseases have been studied broadly and
in detail for a long time (8).
The collection of mutated sequences that cause
single gene disorders started when the exact position of
globin gene mutation was revealed (9). With the help of
advanced molecular and medical biology, as well as DNA
sequencing technologies (10), a large number of mutated
sequences that cause diseases in humans have been
revealed, triggering the construction of several general
and/or central relational databases for human mutations
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were classiﬁed as General Mutation Databases (GMDB)
(11). One of them is the Online Mendelian Inheritance
in Man, (OMIM; http://www.ncbi.nlm.nih.gov/sites/
entrez?db=omim) which provides 19738 OMIM terms
detailing a number of human diseases with 16336 Allelic
Variants (AV) records, of which most describe disease-
producing mutations (12–14) (as of 02-August-2008).
The OMIM AV ﬁeld only contains gene names, mutation
information and some related descriptions organized by
experts in text format; however, mutated protein
sequences are not available. The Human Gene Mutation
Database (HGMD; http://www.hgmd.cf.ac.uk/ac/index.
php; as of June 22, 2008) has archived 57294 mutations
in a academic version and 79098 mutations in HGMD
Professional as a commercial version that contains the
largest number of human gene mutations (15). Although
the academic version of HGMD provides cDNA
sequences for each normal gene in public, it does not
provide mutated amino acid sequences. One interesting
thing is that the contents of the two largest datasets,
OMIM and HGMD, do not overlap, i.e., 1647 of 2263
genes (72.78%) having mutation causing disease from
two databases were shared, and 143 and 473 genes with
mutation data were not present in HGMD and OMIM,
respectively (11). In addition, the number of mutations
in each gene is also largely diﬀerent; only 450 genes
(19.89%) show the same number of mutations (11), indi-
cating that the total number of human disease-related
mutated sequences characterized until now should be
larger than the mutated sequences in each database. As
another resource, SwissProt also serves 38022 polymor-
phisms (only for point mutations) occurred in human
genes, of which some have disease information described
with OMIM terms (16).
On the other hand, the locus-speciﬁc databases
(LSDBs), another type of mutation database, started
being constructed after the revelation of globin mutations
(17). LSDBs have high quality information on the
gene itself and its mutations (11) and 672 LSDBs listed
in the Human Genome Structural Variation Project
web site (http://www.hgvs.org/dblist/glsdb.html; as of
March 9, 2007) are available now (18). Single nucleo-
tide polymorphisms (SNPs) in humans are another
resource for disease-associated mutations and many data-
bases have been developed for revealing the eﬀects of
SNPs on protein functionalities and human diseases
(8,19–26).
Mass spectrometry (MS) is an analytical technique for
characterizing the chemical composition of a sample based
on the mass-to-charge ratio of charged material. Tandem
mass spectrometry, known as MS/MS, has been used as
a high-throughput method to identify amino acids of
fragmented proteins digested by trypsin typically (27).
MS technique has been used not only to identify pro-
teomes but also to identify several modiﬁcations of pro-
teins, such as post-translational modiﬁcation (PTM) (28).
As a consequence, 2695 MS/MS results have been
accumulated in Proteinpedia (http://www.humanprotein-
pedia.org/) (29,30). Besides PTM, protein mutations can
also be identiﬁed from the MS/MS results because they
have slightly diﬀerent amino acids compared to the
normal proteins, which can make MS peaks shift (31).
For identifying these various forms of proteins, several
widely used database-search software programs, such
as SEQUEST (http://ﬁelds.scripps.edu/sequest/), Mascot
(32) and X!Tandem (33), which interpret MS peaks
and match them to the set of sequences with their own
algorithms, have been developed. To detect disease-
associated mutations in human proteins by these pro-
grams, specialized datasets are required. However, to
date, there are no proper datasets optimized for identify-
ing human disease-related mutated proteins based on MS
technology. MSIPI, which was modiﬁed based on the
International Protein Index (IPI), was developed to iden-
tify human mutated sequences. MSIPI retained its rela-
tively compact nature while maximizing the chance of
identifying sequence variants (19), which contain mutated
sequence information but do not provide any disease
information.
To surmount these deﬁciencies in studying human
mutated proteins, we developed a web-based system to
identify human disease-related mutated sequences
from MS results. Termed, the Systematic Platform for
Identifying Mutated Protein (SysPIMP; http://pimp.
starﬂr.info/), SysPIMP embraces Protein Mutated
Database (PMD; http://pmd.ddbj.nig.ac.jp/) (34), OMIM
AV mutation information (13) and human polymorphisms
and disease mutations from SwissProt (16) with seven dif-
ferent sources of human normal proteins. In total,
SysPIMP collected 35497 non-redundant human disease-
related mutated proteins of which 21513 were from
OMIM, 7261 from PMD and 15308 from SwissProt. To
handle disease information uniformly, SysPIMP is based
on the framework of OMIM integrating mutation infor-
mation dispersed in other public databases and it maps all
disease-related mutated proteins to certain OMIM terms.
Based on these criteria, SysPIMP provides more compre-
hensive and integrative datasets that users can access
freely. To demonstrate the possibility that our non-redun-
dant mutated sequences can be a new dataset used for
identifying human disease-related mutated proteins from
MS results by X!Tandem, an open source tool for identify-
ing proteins from tandem MS spectra with new algorithm
(33), was integrated into the SysPIMP with newly devel-
oped interfaces to present human disease-related proteins.
In addition, the web-based BLAST tool was also inte-
grated into our system to meet specialized requirements.
SYSTEM ARCHITECTURE
For managing complicated human gene resources (i.e.
four diﬀerent versions of human genomes) and already
developed bioinformatics programs, such as BLAST and
X!Tandem, SysPIMP was designed and constructed as
three layers: (i) the data warehouse layer which aims
to manage and process sequences collected from diﬀer-
ent sources, (ii) the pipeline layer which undertakes
the renewal of information, such as the daily update
of OMIM, not only to recover mutated sequences based
on collective human normal proteins, but also to maintain
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based user interfaces both for accessing the databases and
for presenting the results of two Linux-executable bioin-
formatics programs: X!Tandem and BLAST (Figure 1).
In the data warehouse layer, the standardized data-
base structure, which was developed in Comparative
Fungal Genomics Platform (CFGP; http://cfgp.snu.ac.kr/)
(35) and which has been stabilized through several data-
bases (36–40), was implemented for dealing with diﬀer-
ently originated sequences: PMD, OMIM, SwissProt,
MSIPI and four diﬀerent versions of human genomes
(Ensembl release 48, NCBI Celera assembly, NCBI
HuRef assembly and NCBI reference genome version
36.3) (13,16,34,41–44) having diverse additional infor-
mation. With this structure, heterogeneous sequences
can be entered into two bioinformatics tools and those
results manipulated in the same way.
The pipeline layer in SysPIMP plays six obvious
roles: (i) updating the contents of OMIM for following a
daily-updated OMIM database, (ii) collecting and
removing redundancy of human normal proteins
(Integrated annotated Human normal Proteins or IHPs)
from seven sources, (iii) based on IHPs, generating
mutated sequences from gene name and position in
OMIM AV ﬁeld, (iv) integrating and updating disease-
related mutated sequences of human from three diﬀerent
sources: PMD, OMIM and SwissProt Human polymorph-
isms and disease mutations, (v) bridging between user
requests via a web interface and two programs, such as
X!Tandem and BLAST and (vi) maintaining X!Tandem
and BLAST datasets with the latest sequences. The com-
ponents belonging to this pipeline were developed using
Java and PERL. All processes of the pipeline keep old
primary keys for maintaining already existed data, enabl-
ing users to track back their own data in the SysPIMP
web site.
The web interface was designed to provide an eﬃcient
way to search the complex data deposited in SysPIMP.
For example, IHPs derived from seven diﬀerent sources
can be traced back to the original sequences with present-
ing its related information, and they are also linked to
mutated sequences with disease information described as
OMIM terms. In the interface for X!Tandem, the analysis
results will be stored in the database under the X!Tandem
history browser. In the case of BLAST search, a graphical
interface will be provided for each result. In addition, the
SNU Genome Browser (http://genomebrowser.snu.ac.kr/;
Jung et al., under revision) was implemented to present
human genome contexts around human disease-related
genes for further studies.
DATASET OF HUMAN DISEASE-RELATED
MUTATED PROTEINS
For providing comprehensive dataset of human disease-
related mutated sequences, mutated sequences deposited
in PMD, OMIM and SwissProt Human polymorphisms
and disease information described in OMIM terms were
used. Because they were stored in diﬀerent formats, the
programs for dealing with each source were developed
independently for integrating them into the standardized
structure.
Mapping PMDdisease information to OMIM terms
PMD (http://pmd.ddbj.nig.ac.jp/) had been updated
until 2007, providing plentiful disease-related mutated
sequences from many organisms including humans (34).
The latest version of PMD (March 26, 2007) serves
218873 mutated sequences from 45239 entries in many
species, containing the disease information as text descrip-
tion. Only 2805 (15.85%) entries out of 17702 human
entries have disease information. Nine hundred and
sixty-four diﬀerent disease names out of 2805 entries
were mapped to 967 OMIM terms after correcting typos
in the disease name ﬁeld. Finally, a non-redundant 7261
out of 9808 mutated sequences that have disease informa-
tion described as OMIM term were registered in SysPIMP.
Data Warehouse
Web-based
User Interface
Pipeline Layer
X!Tandem
BLAST
Human
Normal
Proteins
OMIM,
PMD,
Swiss-
Prot...
Human
Mutated
Proteins
Figure 1. The system architecture of SysPIMP. The overall system
structure of SysPIMP is comprised of three layers. Data warehouse
embraces human normal proteins collected from seven diﬀerent sources
and human mutated proteins derived from four diﬀerent sources, pres-
ented as database diagram in the lower part. Pipeline layer plays a role
in updating external databases, such as OMIM, PMD and SwissProt
and for bridging between external programs, such as X!Tandem and
BLAST programs, and users. Web interface provides the gateway for
users not only to access all database contents but also to present
X!Tandem and BLAST results as various formats on the web.
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proteins from sevendifferent sources
OMIM Allelic Variants (AV) ﬁeld provides gene names,
mutation information, and disease descriptions organized
by experts, without mutated sequences. The OMIM has
been managed as a text-based database, so that the data
cannot be directly used for constructing relational data-
bases even though it contains highly organized informa-
tion. Not all the gene names used in the OMIM AV ﬁeld
were matched to the gene names used in other human gene
databases, such as SwissProt (16), for ﬁnding original
amino acid sequences. Moreover, original and changed
amino acid sequences at mutated position described in
AV ﬁeld were not matched to rescued sequences from
other human protein sources, hampering our recovery of
mutated sequences. To overcome these problems, the lar-
gest set of gene names with amino acid sequences as well as
corrected positions of mutation is required.
Based on seven separate sources of human proteins, such
as four diﬀerent versions of human genomes (Ensembl
release 48, NCBI Celera assembly, NCBI HuRef assembly,
and NCBI human reference genome), and normal protein
sequences in PMD, SwissProt, and MSIPI, 99410 non-
redundant human proteins designated as Integrated anno-
tated Human normal Proteins (IHPs) were collected with
73132 distinct gene names. Because IHPs were collected
based only on amino acid sequences, IHPs contain possible
isoforms of certain genes from seven diﬀerent sources with
the result that the number of IHPs is larger than the
number of distinct gene names. Especially for the collec-
tion of gene names, two additional resources were used:
genemap data in OMIM database and OMIM Mutation
Search constructed by Dr Anderw C.R. Martin’s Group
(http://www.bioinf.org.uk/omim/). The resources helped
us to correct mutation positions in OMIM.
Eleven diﬀerent regular expressions for extracting muta-
tion types and positions from the OMIM AV ﬁeld were
established. Due to the limited information, such as the
exon/intron structure and nucleotide sequences of each
gene, not all the point mutations including termination,
insertion, deletion and duplication were considered. Based
on IHPs and mutation information, the pipeline for
rescuing disease-related mutated sequences described in
AV ﬁeld was developed as two steps. In the ﬁrst step,
gene names and mutated positions described in AV ﬁeld
were compared with IHPs containing the largest set of
human gene names. For solving the incorrect positions
not matched in the ﬁrst step, the data downloaded from
OMIM Mutation Search (http://www.bioinf.org.uk/
omim/) were used. The unmatched AV records in the
ﬁrst step were compared with the corrected mutated posi-
tions in the OMIM Mutation Search as a second step.
Taken together, a non-redundant 21513 out of 21794
human disease-related mutated sequences from 16336
OMIM AV records were recovered and subsequently
merged into the Integrated Human Mutated Sequences
(IMSs) while removing the redundancy at the amino
acids level (Figure 2A).
Integrating SwissProt Humanpolymorphisms and disease
mutations andMSIPI sequences into SysPIMP
SwissProt Human polymorphisms and disease mutations
database deals with only point mutations of human
genes based on SwissProt protein database (16). In the
current release (Release 55.0 of February 26, 2008),
15964 (41.25%) out of 38022 human polymorphisms
have disease information depicted with OMIM terms.
MSIPI, developed for the optimized dataset of MS data
analysis from IPI (41), contains 44020 mutated sequences
from 70444 normal sequences. All mutated sequences of
both databases were also merged into IMSs in SysPIMP
(Figure 2A).
Comprehensive dataset ofhuman disease-related
mutated proteins
From four sources of human mutated sequences (PMD,
OMIM AV ﬁeld, SwissProt and MSIPI), in total, 35497
(23.57%) out of 151042 non-redundant mutated sequences
have disease information described as OMIM terms
(Figure 2A). Due to the overlap between diﬀerent sources,
Source # of Records # of IMSs # of dIMSs
OMIM  21,794 21,513 21,513
PMD  77,333 60,700 7,261
SwissProt  38,022 38,021 15,308
MSIPI  43,824 42,813 0
Total 180,793 151,042 35,497
A
B
OMIM
SwissProt PMD
15,748
3,715 8,919
1,350
1,470
726 3,569
Figure 2. The number of non-redundant human mutated proteins
(IMSs) in SysPIMP originated from OMIM, PMD and SwissProt.
(A) The table presents the total number of records, IMS and disease-
related IMSs (dIMS) in each source. (B) Three diﬀerent color-coded
circles present the sources of human dIMSs: Orange is OMIM, green
is PMD and blue is SwissProt Human Polymorphisms and Disease
Mutations. Each number on the venn-diagram indicates the absolute
number of sequences.
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sequences is presented as a Venn-diagram (Figure 2B). In
the diagram, MSIPI originated sequences are excluded
because they do not have any disease information. The
1470 disease-related mutated sequences from all three
origins are occupied in 4.14% of all disease-related IMSs,
and only 7115 proteins (20.04%) come from at least two
diﬀerent sources, presenting that three sources have col-
lected diﬀerent disease-related mutated sequences studied
till now.
Disease classification ofIMSs
For classifying human diseases of IMS, the classiﬁcation
system of Human Disease Network (45) was used. The
classiﬁcation system was constructed based on OMIM
terms mentioned in Morbid Map, which is the most com-
plete and best organized list of known disorder-gene
associations (46), covering 1781 (9.02%) out of 19738
OMIM terms. Even though OMIM terms in the Morbid
Map do not cover almost all OMIM terms, around 40%
OMIM terms in IMSs can be classiﬁed via that clas-
siﬁcation well, presenting Morbid map can be used for
classifying disease reasonably. There are 3508 diﬀerent
OMIM terms assigned to 35497 IMSs, among which
1493 (42.56%) terms belong to Morbid Map. Out of
35497 IMSs, 23034 (64.89%) are classiﬁed by OMIM
terms belonging to Morbid Map, showing that the ratio
of the IMSs classiﬁed by the disease classiﬁcation is larger
than the proportion of OMIM terms. Interestingly, 4323
(81.55%) out of the 5301 IHPs which contain one or more
IMSs are assigned to the 23034 IMSs. It shows the usabil-
ity of Human Disease Network by demonstrating that
more than 80% of disease related genes can be classiﬁed
by the disease classiﬁcation of Human Disease Network
(45). Based on this approach for disease classiﬁcation, the
detailed analyses will uncover the feature of human dis-
eases caused by mutation.
WEB-BASED DATASET BROWSERS OF SysPIMP
Because of diverse sources in SysPIMP, many browsers
which allow users to explore diﬀerent types of data on
the web easily were implemented. Each browser provides
not only origin-speciﬁc information with sequences but
also the related information with IHPs and IMSs.
OMIM Browser
OMIM Browser provides the main contents of OMIM
database and mutated sequences originated from OMIM
AV ﬁeld via the pipeline. Related information is linked to
each other in detailed pages. In addition, OMIM classiﬁ-
cation used in this study (45) and detailed list of IHPs and
IMSs are presented.
PMD Browser
In SysPIMP, text-based PMD was processed and reformu-
lated to the relational database for human sequences. Two
thousand, eight hundred and ﬁve entries ﬁltered with the
criteria of human disease-related mutations with normal
and mutated sequences are presented. Curated disease
names in PMD with OMIM terms are also provided via
PMD Browser.
SwissProt/MSIPI Browser
SwissProt Browser provides normal sequences (includ-
ing isoforms) and mutated sequences with disease infor-
mation, supporting the search function for ﬁnding certain
SwissProt sequences by accession number and gene name.
Currently SwissProt Browser contains 30413 human
normal proteins and 38022 polymorphisms. Sequences
from MSIPI, developed as an eﬃcient way to identify
sequence variants in MS results (41), were split into origi-
nal and mutated sequences because sequences of MSIPI
were the concatenated form of several amino acid
sequences. MSIPI Browser serves 70444 entries with
44020 mutated sequences.
HumanGenome Browser
Human Genome Browser contains four versions of human
genomes: Ensembl release 48, NCBI Celera assembly,
NCBI HuRef assembly, and NCBI human reference
genome version 36.3 (42–44). It provides the summary
of genome status, the list and detailed information of
128883 ORFs on totally 11646 contigs with exon struc-
tures. A Chromosomal diagram was constructed based
on Ensembl release 48. With graphical representation of
human genome contexts, mutated positions of human
proteins in SysPIMP are presented via SNU Genome
Browser (http://genomebrowser.snu.ac.kr/; Jung et al.,
under revision).
WEB INTERFACE FOR ANALZYING MASS
SPECTROSCOPY RESULTS USING X!TANDEM
For identifying mutated sequences from MS results, we
developed a specialized web-based interface and datasets
for X!Tandem based on 35 497 Integrated human disease-
related mutated sequences (IMSs). SysPIMP provides nine
diﬀerent datasets: ﬁve normal sequence sets from human
genomes and SwissProt, two mutated sequence sets from
PMD and MSIPI, and two integrated datasets (IHP and
disease-related IMSs).
The interface for inputting parameters of X!Tandem
was designed based on the web site managed by thegpm
group (http://human.thegpm.org/tandem/thegpm_tand
em_a.html). In the result pages, four diﬀerent views are
available to users: (i) Disease view, (ii) Sequence view,
(iii) Chromosome view and (iv) Raw Data view. Disease
view displays the list of possible human disease-related
mutated sequences from uploaded MS data with disease
information (Figure 3A). The criteria for ﬁltering them
consist of two steps: (i) ﬁnding mutated sequences
which have disease information in the X!Tandem results
and (ii) checking whether the matched region contains
mutated amino acids or not. Sequence view was designed
for showing all results of X!Tandem because some users
want to know all matched proteins with detailed informa-
tion (Figure 3B). Chromosome view draws the map of
human chromosomes based on Ensembl release 48 with
red bars of disease-related mutated proteins. It provides
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an interactive diagram, with the link to the detailed infor-
mation of mutated proteins (Figure 3C). Raw Data view
shows the detailed options of X!Tandem and XML ﬁle
generated by X!Tandem as a result (Figure 3D).
All X!Tandem results will be stored in the SysPIMP
along with the user’s information, so that the user can
browse the X!Tandem results executed previously without
running the program again.
MAINTAINENCE AND FUTURE PERSPECTIVES
To update disease information, the OMIM database will
be downloaded and applied to the SysPIMP database
monthly. Based on the latest information, the pipeline
for maintaining the mutated sequences from OMIM will
update the database as well. The PMD, SwissProt Human
polymorphisms and disease mutations, MSIPI and human
genomes will be monitored and periodically updated as
will the pipeline and all related information.
SysPIMP is the integrated platform not only for collect-
ing human disease-related mutated sequences but also for
providing the programs to identify mutated proteins from
the mass spectrometry results. For expanding the data
warehouse for disease-related mutated sequences in
humans with accurate disease information, diverse locus-
speciﬁc disease related databases (LSDB) (18), such as
IDBases (47) and SNP-related databases, such as dbSNP
(48), can be integrated. Using the standardized form for
integrating external programs, other programs for analyz-
ing MS result data, such as Mascot (32), can be incorpo-
rated in SysPIMP to enhance the ability to identify
disease-related proteins.
A
C
B
D
Figure 3. Specialized web interface of X!Tandem for identifying disease-related mutated proteins from mass spectrometry results. SysPIMP provides
four diﬀerent views of X!Tandem results. (A) Disease view presents the list of identiﬁed proteins which are linked to disease-related mutated
sequences from MS results. Detected position from X!Tandem and mutated position are displayed in one line. (B) Sequence view shows the
whole list of identiﬁed proteins of MS results. (C) Chromosome view draws the chromosomal map with human disease-related proteins identiﬁed
from MS result, which have chromosomal positional information. If the label is clicked by a user, detailed information of IMS will appear. (D) Raw
Data view prints XML ﬁle generated by X!Tandem.
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